FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I), in which A is selected from a group , , , and ; R1 is -CH3, -CH2F, -CHF2, -CH2CH3, -CH2OCH3 or -CH2OCH2CH3; R2 and R3 is selected independently from -H, halogen, -CH3, -OCH3 or -OCH2CH3; R4 is -CF3, cyano, -CH3, -C(O)ORa or -C(O)NRbRc; Ra is -H, or (C1-C2)alkyl; each Rb and Rc is independently H; and n is integer from 0 to 1; or when A is (A-3) or (A-5), R1 is-CH3, -CH2F, -CH2OCN3 or -CHF2, and n is equal to 0, then at least one of R2 and R3 is not H. Invention also relates to individual compounds, to a pharmaceutical composition, to a method of treating a CNS related disorder associated with GABA function, to a method of treating a seizure, to a method of treating epilepsy, to a method of treating epileptic status.
H(I).
EFFECT: technical result is obtaining novel compounds of formula (I), having properties of modulator GABAA, which can be useful in treating a CNS related disorder.
32 cl, 71 ex, 4 tbl, 22 dwg
Title | Year | Author | Number |
---|---|---|---|
19-NOR NEUROACTIVE STEROIDS AND METHODS OF USING THEM | 2014 |
|
RU2700264C2 |
19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2812930C2 |
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2528393C9 |
ANTITUMORAL COMPOUNDS | 2008 |
|
RU2489429C2 |
ANTICANCER DIHYDROPYRAN-3-ONE COMPOUNDS | 2007 |
|
RU2444519C2 |
OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2742333C2 |
SULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF INHIBITION OF FIBRIN EFFECT AND A METHOD OF TREATMENT OF MAMMALIAN WITH THROMBOSIS | 1992 |
|
RU2116296C1 |
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2493147C2 |
INHIBITORS OF PRENYLTRANSFERASES | 1997 |
|
RU2186776C2 |
Authors
Dates
2019-09-05—Published
2015-05-29—Filed